Stock Scorer

Globus Medical Inc (GMED)

Globus Medical Inc reported revenue of 789.6M USD for the quarter ending 30 June 2026, up 5.9% from 745.3M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 789.6M +5.9%
Gross Profit Q2 '24 · ending 30 June 2024 369.7M +71.8%
Operating Income Q2 '26 · ending 30 June 2026 182.4M +139.7%
Net Income Q2 '26 · ending 30 June 2026 151.6M -25.3%
Cost of Revenue Q2 '26 · ending 30 June 2026 241.4M -2.9%
Operating Cash Flow Q2 '26 · ending 30 June 2026 209.7M +169.4%
Free Cash Flow Q2 '26 · ending 30 June 2026 176.6M +464.1%
Shares Outstanding Q2 '26 · ending 30 June 2026 137.4M -1.7%
EPS Q2 '26 · ending 30 June 2026 3.90 +50.0%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 2.9B479.8M537.9M588.8M
20242024-12-31 2.5B166M103M405.2M
20232023-12-31 1.6B133.1M122.9M165.2M
20222022-12-31 1B228M190.2M104.4M
20212021-12-31 958.1M172M149.2M219.4M
20202020-12-31 789M111.4M102.3M135.1M
20192019-12-31 785.4M172M155.2M101.2M
20182018-12-31 713M169.3M156.5M121.9M
20172017-12-31 636M161.8M107.3M107.8M
20162016-12-31 564M154.1M104.3M106.9M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30789.6M
Q1 '262026-03-31759.9M
Q4 '252025-12-31826.4M
Q3 '252025-09-30769M
Q2 '252025-06-30745.3M
Q1 '252025-03-31598.1M
Q4 '242024-12-31657.3M
Q3 '242024-09-30625.7M
Q2 '242024-06-30629.7M
Q1 '242024-03-31606.7M
Q4 '232023-12-31616.5M
Q3 '232023-09-30383.6M
Q2 '232023-06-30291.6M
Q1 '232023-03-31276.7M
Q4 '222022-12-31274.5M
Q3 '222022-09-30254.1M
Q2 '222022-06-30263.6M
Q1 '222022-03-31230.5M
Q4 '212021-12-31250M
Q3 '212021-09-30229.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '242024-06-30369.7M
Q1 '242024-03-31365.2M
Q4 '232023-12-31351M
Q3 '232023-09-30248.2M
Q2 '232023-06-30215.1M
Q1 '232023-03-31205.9M
Q4 '222022-12-31203.9M
Q3 '222022-09-30188.7M
Q2 '222022-06-30195.2M
Q1 '222022-03-31171.4M
Q4 '212021-12-31188.2M
Q3 '212021-09-30171.2M
Q2 '212021-06-30187.2M
Q1 '212021-03-31172.3M
Q4 '202020-12-31172.6M
Q3 '202020-09-30159M
Q2 '202020-06-3098.3M
Q1 '202020-03-31141.7M
Q4 '192019-12-31162.9M
Q3 '192019-09-30150.8M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30182.4M
Q1 '262026-03-31150.4M
Q4 '252025-12-31169.3M
Q3 '252025-09-30137.4M
Q2 '252025-06-3076.1M
Q1 '252025-03-3197M
Q4 '242024-12-3160.3M
Q3 '242024-09-3048.1M
Q2 '242024-06-3049.6M
Q1 '242024-03-318M
Q4 '232023-12-3110.1M
Q3 '232023-09-30404K
Q2 '232023-06-3066.2M
Q1 '232023-03-3156.4M
Q4 '222022-12-3154M
Q3 '222022-09-3059.7M
Q2 '222022-06-3067.8M
Q1 '222022-03-3146.4M
Q4 '212021-12-3118.2M
Q3 '212021-09-3053.3M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30151.6M
Q1 '262026-03-31124.3M
Q4 '252025-12-31140.6M
Q3 '252025-09-30119M
Q2 '252025-06-30202.8M
Q1 '252025-03-3175.5M
Q4 '242024-12-3126.5M
Q3 '242024-09-3051.8M
Q2 '242024-06-3031.8M
Q1 '242024-03-31-7.1M
Q4 '232023-12-3115M
Q3 '232023-09-30998K
Q2 '232023-06-3057.7M
Q1 '232023-03-3149.1M
Q4 '222022-12-3150.1M
Q3 '222022-09-3047.4M
Q2 '222022-06-3054.6M
Q1 '222022-03-3138.1M
Q4 '212021-12-3115.1M
Q3 '212021-09-3047.2M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30241.4M
Q1 '262026-03-31234.1M
Q4 '252025-12-31261.1M
Q3 '252025-09-30252.5M
Q2 '252025-06-30248.8M
Q1 '252025-03-31195.4M
Q4 '242024-12-31263.4M
Q3 '242024-09-30270.5M
Q2 '242024-06-30260M
Q1 '242024-03-31241.5M
Q4 '232023-12-31265.5M
Q3 '232023-09-30135.4M
Q2 '232023-06-3076.5M
Q1 '232023-03-3170.8M
Q4 '222022-12-3170.6M
Q3 '222022-09-3065.5M
Q2 '222022-06-3068.5M
Q1 '222022-03-3159.2M
Q4 '212021-12-3161.8M
Q3 '212021-09-3058.6M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30209.7M
Q1 '262026-03-31202.4M
Q4 '252025-12-31248.6M
Q3 '252025-09-30249.7M
Q2 '252025-06-3077.9M
Q1 '252025-03-31177.3M
Q4 '242024-12-31210.3M
Q3 '242024-09-30203.7M
Q2 '242024-06-3054.3M
Q1 '242024-03-3152.4M
Q4 '232023-12-31104.7M
Q3 '232023-09-3050.5M
Q2 '232023-06-3035M
Q1 '232023-03-3153.3M
Q4 '222022-12-3164M
Q3 '222022-09-3032.9M
Q2 '222022-06-3036.9M
Q1 '222022-03-3144.7M
Q4 '212021-12-3176.3M
Q3 '212021-09-3077.3M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30176.6M
Q1 '262026-03-31162.7M
Q4 '252025-12-31202.4M
Q3 '252025-09-30213.9M
Q2 '252025-06-3031.3M
Q1 '252025-03-31141.2M
Q4 '242024-12-31193.2M
Q3 '242024-09-30161.7M
Q2 '242024-06-3026.5M
Q1 '242024-03-3123.8M
Q4 '232023-12-3181.8M
Q3 '232023-09-3028.9M
Q2 '232023-06-3017.2M
Q1 '232023-03-3137.3M
Q4 '222022-12-3145.6M
Q3 '222022-09-3020.9M
Q2 '222022-06-3013.1M
Q1 '222022-03-3124.7M
Q4 '212021-12-3159.2M
Q3 '212021-09-3059.5M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30137.4M
Q1 '262026-03-31138.2M
Q3 '252025-09-30135.4M
Q2 '252025-06-30136.5M
Q1 '252025-03-31139.8M
Q3 '242024-09-30138.1M
Q2 '242024-06-30137M
Q1 '242024-03-31135.4M
Q3 '232023-09-30115.2M
Q2 '232023-06-30101.8M
Q1 '232023-03-31102.2M
Q3 '222022-09-30101.4M
Q2 '222022-06-30102.9M
Q1 '222022-03-31104.1M
Q3 '212021-09-30104.4M
Q2 '212021-06-30103.5M
Q1 '212021-03-31102.4M
Q3 '202020-09-30100.5M
Q2 '202020-06-3097.5M
Q1 '202020-03-31102.1M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-303.90
Q1 '262026-03-314.29
Q4 '252025-12-313.93
Q3 '252025-09-303.10
Q2 '252025-06-302.60
Q1 '252025-03-311.34
Q4 '242024-12-310.75
Q3 '242024-09-300.65
Q2 '242024-06-300.28
Q1 '242024-03-310.62
Q4 '232023-12-311.15
Q3 '232023-09-301.55
Q2 '232023-06-302.01
Q1 '232023-03-311.97
Q4 '222022-12-311.86
Q3 '222022-09-301.51
Q2 '222022-06-301.49
Q1 '222022-03-311.36
Q4 '212021-12-311.43
Q3 '212021-09-301.81